Mengjun Zhang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters.
Journal: Frontiers in oncology
Published: July 01, 2022
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer.
Journal: Frontiers in genetics
Published: June 26, 2022
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: January 26, 2022
A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer.
Journal: Frontiers in genetics
Published: November 15, 2021
UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
Journal: Journal of ovarian research
Published: October 03, 2021
Platelet-derived growth factor-D expression mediates the effect of differentiated degree on prognosis in epithelial ovarian cancer.
Journal: Journal of cellular biochemistry
Published: March 06, 2018
Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 15, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026